Compare PFE & ING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFE | ING |
|---|---|---|
| Founded | 1849 | 1991 |
| Country | United States | Netherlands |
| Employees | N/A | 60000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.6B | 89.9B |
| IPO Year | 2013 | N/A |
| Metric | PFE | ING |
|---|---|---|
| Price | $24.79 | $31.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 1 |
| Target Price | ★ $29.29 | N/A |
| AVG Volume (30 Days) | ★ 28.3M | 4.1M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 6.55% | 4.50% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $62,579,000,000.00 | N/A |
| Revenue This Year | N/A | $0.59 |
| Revenue Next Year | N/A | $6.55 |
| P/E Ratio | $53.34 | ★ $11.40 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.11 | $21.63 |
| 52 Week High | $28.75 | $32.22 |
| Indicator | PFE | ING |
|---|---|---|
| Relative Strength Index (RSI) | 33.94 | 61.08 |
| Support Level | $23.96 | $27.82 |
| Resistance Level | $24.88 | N/A |
| Average True Range (ATR) | 0.45 | 0.52 |
| MACD | -0.07 | 0.15 |
| Stochastic Oscillator | 0.87 | 84.11 |
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions, ING has built up a global footprint. The 2008 financial crisis forced ING to seek government support—a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market-leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.